TargetMol Chemicals Inc.
Firmenname:
TargetMol Chemicals Inc.
Telefon:
-
E-Mail:
marketing@targetmol.com
Nationalität:
China
URL:
https://www.targetmol.cn/
Produkte insgesamt:
28091
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
Produktkatalog
NVP-BSK805 trihydrochloride
2320258-95-3
C27H29ClF2N6O
5-HT7R antagonist 1 free base
2337008-64-5
C14H17ClN4
GNE-274
2369048-69-9
C29H31NO4
(S,R,S)-AHPC-C2-NH2 dihydrochloride
2341796-73-2
C25H36ClN5O4S
LAS17
2362527-67-9
C15H20Cl2N4O2
Cl-PEG6-acid
2365309-92-6
C14H27ClO8
5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyuridine
5'-O-[Bis(4-methoxyphenyl)benzyl]-2'-desoxyuridin
23669-79-6
C30H30N2O7
ARB-272572
2368182-63-0
C32H36N6O4
Polyketide synthase 13-IN-1
2345638-96-0
C21H19NO4
(±)-Phrymarolin II
23720-86-7
C23H22O10
Propargyl-Tos
23418-85-1
C11H12O3S
Protein kinase inhibitors 1 hydrochloride
2321337-71-5
C18H18ClN5O3S
GSK143 dihydrochloride
2341796-81-2
C17H23ClN6O2
LysoTracker Red
231946-72-8
C20H24BF2N5O
JMS-17-2 hydrochloride
2341841-07-2
C25H27Cl2N3O
Legumain inhibitor 1
2361157-34-6
C23H25N5O4S
Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride
2341841-02-7
C17H19ClN4O6
CDK7-IN-2 hydrochloride hydrate
2326428-24-2
C26H42ClN7O4
(S,R,S)-AHPC-C6-NH2 dihydrochloride
2341796-77-6
C29H44ClN5O4S
IDO1-IN-7
2351199-98-7
C22H19ClFN3O3
8-Br-GTP
23197-98-0
C10H15BrN5O14P3
β-Lactamase-IN-6
2326468-84-0
C15H23FN2O5S
TMX-4100
2367619-63-2
C11H10N4O2S
Pomalidomide-PEG6-NH2 hydrochloride
2341841-01-6
C25H36ClN3O10
ALK-IN-9
2359662-39-6
C20H21FN6O3
Thalidomide-O-C2-acid
2369068-42-6
C16H14N2O7
8-Bromo-ATP
23567-97-7
C10H15BrN5O13P3
AZD8154
2215022-45-8
C27H29N5O4S2
CBP/p300-IN-8
2304416-91-7
C27H31N3O4
MY33-3
2204280-41-9
C16H13F6NS2
DDO-2093
2250024-74-7
C29H37ClFN9O3
Polyketide synthase 13-IN-3
2221801-50-7
C21H19NO4
TBK1/IKKε-IN-6
2306877-20-1
C31H36F2N8O4
nAChR agonist CMPI hydrochloride
2250025-94-4
C18H20Cl2N4O
Suntinorexton
2274802-89-8
C23H28F2N2O4S
KRH-3955 hydrochloride
2253744-59-9
C28H46ClN7
LpxC-IN-5
2253951-38-9
C21H24N4O5
Mosliciguat
2231749-54-3
C41H36ClF3N2O5
HPK1-IN-19
2227609-33-6
C27H32N7O2P
BPBA
223463-14-7
C5H5BBrNO2
Mutant IDH1-IN-6
2230263-60-0
C28H36N6O3
IDO1-IN-11
2306411-34-5
C22H17ClFN3O3
NH2-PEG5-C6-Cl hydrochloride
2241669-16-7
C16H35Cl2NO5
Gemnelatinib
2225123-30-6
C30H29FN6O2
PRMT5-IN-14
2278356-90-2
C18H18Cl2N4O4
GluN2B receptor modulator-1
2222010-71-9
C17H15F3N4O2S
SSAO inhibitor-1
2242883-04-9
C17H24FN5O2
(E/Z)-E64FC26
2285446-67-3
C19H23F3O2
LYN-1604 hydrochloride
2216753-86-3
C33H44Cl3N3O2
UK-59811 hydrochloride
2250025-89-7
C22H30BrClN2O5
RAD51-IN-3
2301084-99-9
C31H41N5O5S2
Aβ/tau aggregation-IN-1
2252162-81-3
C25H21IN2O
TH5427 hydrochloride
2253744-57-7
C20H21Cl3N8O3
RORγ agonist 1
2260631-91-0
C29H27ClF4N2O4S
MYC-IN-2
2244979-61-9
C25H17N3O2S
BPK-21
2305052-77-9
C23H16Cl2F3NO2
Gunagratinib
2211082-53-8
C22H25N5O4
c-ABL-IN-1
2304918-82-7
C17H15ClFN3OS
CM121
2204230-40-8
C24H17FN4O3S
RGLS4326
2229964-07-0
C95H115F3N32O51P8S8
(Rac)-CP-601927 hydrochloride
230615-01-7
BIIB091
2247614-80-6
C28H34N10O2
AR-C141990 hydrochloride
2250019-94-2
C26H29ClN4O4S
Nepinalone hydrochloride
22443-55-6
C18H26ClNO
KSC-34
2226201-97-2
C21H28ClN7O
ARX-1796
2245880-46-8
C14H23N3O8S
DENV-IN-2
2253675-62-4
C29H26ClF3N2O6
Thalidomide-piperazine-Boc
2222114-64-7
C22H26N4O6
CXCR4 antagonist 2
2243636-57-7
C25H36N6
APJ receptor agonist 1
2287153-38-0
C31H26ClN3O3
D-4-Hydroxyphenylglycine
D-N-(4-Hydroxyphenyl)glycin
22818-40-2
C8H9NO3
Pomalidomide 4'-PEG3-azide
2271036-46-3
C21H26N6O7
Lenalidomide-I
2207541-30-6
C13H11IN2O3
BPK-25
2305052-86-0
C21H17ClN4O2
Influenza A virus-IN-1
2250313-14-3
C27H20F6N2O3
Alogabat
2230009-48-8
C21H23N5O4
S1P2 antagonist 1
2262402-83-3
C23H21ClN4O4
BAY-6672
2247517-53-7
C26H27BrClN3O3
Monoethyl phthalate
2306-33-4
C10H10O4
Loreclezole hydrochloride
2227372-56-5
C10H7Cl4N3
Diflomotecan
186668-70-2
C21H16F2N2O4
S2157
2262488-39-9
C23H28ClF2N3O2
Janelia Fluor 549 TFA
2245946-45-4
C29H23F3N2O7
Boc-bipiperidine-ethynylbenzoic acid
2308497-81-4
C24H32N2O4
Tinengotinib
2230490-29-4
C20H19ClN6O
Firazorexton
2274802-95-6
C22H25F3N2O4S
BMT-297376
2251031-81-7
C23H29F2N3O3
Etavopivat
2245053-57-8
C22H23N3O6S
BRK inhibitor P21d hydrochloride
2250025-98-8
C23H23ClFN7O2
SHP389
2235394-90-6
C23H29ClN8O2
Elomotecan hydrochloride
220997-99-9
C29H33Cl2N3O4
Pomalidomide-C7-COOH
2225940-51-0
C21H25N3O6
BCL6-IN-5
2253878-09-8
C17H19Cl2N5O2
S2116
2262489-89-2
C22H26ClF2N3O2
Multitarget AD inhibitor-1
2205015-77-4
C29H38N2O
PDE12-IN-1
2259620-80-7
C31H27BrFN5O3
RORγt inverse agonist 23
2230779-18-5
C26H33NO5S
BCR-ABL-IN-3
2240191-12-0
C20H17ClF2N4O3S
DMNPE-4 AM-caged-calcium
2253744-58-8
C34H47N3O22
Bisabolone oxide A
[S-(R*,R*)]-Dihydro-2,2,6-trimethyl-6-(4-methyl-3-cyclohexen-1-yl)-2H-pyran-3(4H)-on
22567-38-0
C15H24O2
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
Copyright 2019 © ChemicalBook. All rights reserved